Health Headlines: From Ebola Breakthroughs to Global Drug Deals
Published on: July 4, 2026, 2:29 a.m. | Source: Devdiscourse
The U.S. FDA investigates anesthesia complications in patients with Venezuelan ancestry. AstraZeneca partners with CSPC for kidney disease drugs. Trials for Bundibugyo Ebola treatment begin in DRC. The U.S. provisional mortality rate drops, but flu deaths rise. Tanzania receives U.S. health investment. Celea advances lung disease drug trials.
